Senior insider sale
President and CEO at VERA THERAPEUTICS, INC. — senior position signals high conviction
$5.71M
125.63K shares
What this filing means
FORDYCE MARSHALL plans to sell 125.63K shares of VERA THERAPEUTICS, INC. valued at approximately $5.71M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/11/2024ACC: 0001950047-24-009703
DirectorOfficer· President and CEO
Since May 2021
125.63K
Shares to sell
$5.71M
Approx. market value
17.50K
Acquired (3 months)
1
Planned
5 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
12/11/2024
17.50KTotal acquired17.50K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/11/2024 | Exercise of Stock Options Cash | 17.50K | — |
| Total | 17.50K | ||
Planned & Completed Dispositions6
Completed
—Completed
Units to sell
19.38K
Market value
$929.6K
11/25/2024
—Completed
Units to sell
30.63K
Market value
$1.52M
11/13/2024
—Completed
Units to sell
19.38K
Market value
$782.6K
10/23/2024
—Completed
Units to sell
15.63K
Market value
$597.6K
10/9/2024
—Completed
Units to sell
23.13K
Market value
$1.06M
9/25/2024
Planned — Approximate Date
NASDAQPlanned
Units to sell
17.50K
Market value
$821.1K
12/11/2024
Total
Units
125.63K
Value
$5.71M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/25/2024 | 19.38K | $929.6K | — | Completed |
11/13/2024 | 30.63K | $1.52M | — | Completed |
10/23/2024 | 19.38K | $782.6K | — | Completed |
10/9/2024 | 15.63K | $597.6K | — | Completed |
9/25/2024 | 23.13K | $1.06M | — | Completed |
| Planned — Approximate Date | ||||
12/11/2024 | 17.50K | $821.1K | NASDAQ | Planned |
| Total | 125.63K | $5.71M | ||